Related Experiment Videos

First report of septicaemic melioidosis in Hong Kong

Insights

Melioidosis, a severe infection caused by Pseudomonas pseudomallei, led to fatal septicaemia in four of five patients in Hong Kong. Early ceftazidime treatment is recommended for this potentially endemic disease.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Melioidosis, caused by Pseudomonas pseudomallei, is a serious bacterial infection.
  • Septicaemia (blood infection) is a severe manifestation of melioidosis.
  • The disease may be endemic in certain regions, including Hong Kong.

Purpose of the Study:

  • To report the first cases of septicaemic melioidosis in Hong Kong.
  • To highlight the clinical presentation and outcomes of this infection.
  • To provide evidence for the endemicity of melioidosis in the region.

Main Methods:

  • Clinical case review of five patients with Pseudomonas pseudomallei septicaemia.
  • Analysis of patient demographics, clinical features, and treatment outcomes.
  • Soil sampling and serological surveys to assess environmental presence and population immunity.

Main Results:

  • Five patients developed Pseudomonas pseudomallei septicaemia; three had concurrent pneumonia.
  • Four patients died, indicating high mortality.
  • Risk factors included advanced age, diabetes mellitus, and immunosuppression (steroid therapy).
  • Clinical presentation mimicked other Gram-negative septicaemia.
  • Soil and serological data supported endemicity in Hong Kong.

Conclusions:

  • Septicaemic melioidosis is a life-threatening condition with high mortality.
  • Early diagnosis and prompt treatment with bactericidal anti-Pseudomonal cephalosporins, like ceftazidime, are crucial.
  • Melioidosis may be an under-recognized endemic disease in Hong Kong, necessitating further investigation and awareness.

Related Concept Videos